pncA mutations in mycobacterium tuberculosis is a strong predictor of poor treatment outcome in the therapy of multidrug resistant tuberculosis
Author(s) -
Dongye Li,
Yi Hu
Publication year - 2016
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2016.02.246
Subject(s) - medicine , pyrazinamide , tuberculosis , mycobacterium tuberculosis , cohort , sputum , drug resistance , multi drug resistant tuberculosis , multiple drug resistance , genotype , oncology , gene , genetics , pathology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom